Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

NCT05357560 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants

NCT03580824 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

NCT02925403 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults

NCT05385471 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1

NCT02572388 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

NCT05790889 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali

NCT06080243 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

NCT04318002 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

NCT06958198 ·Status: RECRUITING ·Phase: PHASE1

A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults

NCT03947190 ·Status: TERMINATED ·Phase: PHASE2

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

NCT02207816 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

NCT07009847 ·Status: RECRUITING

Infant Malaria Vaccine Schedule Optimization

NCT06879327 ·Status: RECRUITING ·Phase: PHASE2

Dose Finding Trial of R21/Matrix-M in School Children

NCT07074665 ·Status: RECRUITING ·Phase: PHASE2

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

NCT05380388 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP

NCT02905019 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B

NCT02600975 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children

NCT01148459 ·Status: COMPLETED ·Phase: PHASE3

Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults

NCT07147400 ·Status: RECRUITING ·Phase: PHASE2

VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules

NCT03970993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

NCT07036159 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

NCT05978037 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase Ib Trial of MSP3 LSP in Children in Tanzania

NCT00469651 ·Status: UNKNOWN ·Phase: PHASE1

L9LS-R21 Interaction

NCT07208760 ·Status: WITHDRAWN ·Phase: PHASE2

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

NCT07038837 ·Status: RECRUITING ·Phase: PHASE4